Alkem Laboratories Shares Surge on Q4 Revenue Growth and Positive FY27 Outlook Context Therapeutics Q1 2026 Earnings Narrowing Losses with EPS Beat of 2481 Bitcoins Historic Rallies After Key Milestones Could State Reserve Adoption Fuel a New AllTime High